BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37366362)

  • 21. Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells.
    Yang WN; Ma KG; Chen XL; Shi LL; Bu G; Hu XD; Han H; Liu Y; Qian YH
    Neuroscience; 2014 Oct; 278():276-90. PubMed ID: 25168732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isomerization of Asp7 in Beta-Amyloid Enhances Inhibition of the α7 Nicotinic Receptor and Promotes Neurotoxicity.
    Barykin EP; Garifulina AI; Kruykova EV; Spirova EN; Anashkina AA; Adzhubei AA; Shelukhina IV; Kasheverov IE; Mitkevich VA; Kozin SA; Hollmann M; Tsetlin VI; Makarov AA
    Cells; 2019 Jul; 8(8):. PubMed ID: 31349637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease.
    Oz M; Lorke DE; Yang KH; Petroianu G
    Curr Alzheimer Res; 2013 Jul; 10(6):618-30. PubMed ID: 23627750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoring long-term potentiation impaired by amyloid-beta oligomers: comparison of an acetylcholinesterase inhibitior and selective neuronal nicotinic receptor agonists.
    Kroker KS; Moreth J; Kussmaul L; Rast G; Rosenbrock H
    Brain Res Bull; 2013 Jul; 96():28-38. PubMed ID: 23639920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taming Microglia in Alzheimer's Disease: Exploring Potential Implications of Choline Alphoscerate via α7 nAChR Modulation.
    Cantone AF; Burgaletto C; Di Benedetto G; Pannaccione A; Secondo A; Bellanca CM; Augello E; Munafò A; Tarro P; Bernardini R; Cantarella G
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the α7 nicotinic acetylcholine receptor to prevent progressive dementia and improve cognition in adults with Down's syndrome.
    Deutsch SI; Burket JA; Benson AD
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():131-9. PubMed ID: 24865150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease.
    Wallace TL; Porter RH
    Biochem Pharmacol; 2011 Oct; 82(8):891-903. PubMed ID: 21741954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic deletion of α7 nicotinic acetylcholine receptors induces an age-dependent Alzheimer's disease-like pathology.
    Tropea MR; Li Puma DD; Melone M; Gulisano W; Arancio O; Grassi C; Conti F; Puzzo D
    Prog Neurobiol; 2021 Nov; 206():102154. PubMed ID: 34453977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuroprotective effects of alpha7 neuronal acetylcholine receptor and its roles in the pathogenesis of Alzheimer's disease].
    Qi XL; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):51-5. PubMed ID: 18509986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.
    Parri HR; Hernandez CM; Dineley KT
    Biochem Pharmacol; 2011 Oct; 82(8):931-42. PubMed ID: 21763291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats.
    Chen L; Yamada K; Nabeshima T; Sokabe M
    Neuropharmacology; 2006 Feb; 50(2):254-68. PubMed ID: 16324726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
    Lombardo S; Maskos U
    Neuropharmacology; 2015 Sep; 96(Pt B):255-62. PubMed ID: 25514383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha7 nicotinic acetylcholine receptor-specific agonist DMXBA (GTS-21) attenuates Aβ accumulation through suppression of neuronal γ-secretase activity and promotion of microglial amyloid-β phagocytosis and ameliorates cognitive impairment in a mouse model of Alzheimer's disease.
    Takata K; Amamiya T; Mizoguchi H; Kawanishi S; Kuroda E; Kitamura R; Ito A; Saito Y; Tawa M; Nagasawa T; Okamoto H; Sugino Y; Takegami S; Kitade T; Toda Y; Kem WR; Kitamura Y; Shimohama S; Ashihara E
    Neurobiol Aging; 2018 Feb; 62():197-209. PubMed ID: 29175709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective activation of α7 nicotinic acetylcholine receptor by PHA-543613 improves Aβ25-35-mediated cognitive deficits in mice.
    Sadigh-Eteghad S; Talebi M; Mahmoudi J; Babri S; Shanehbandi D
    Neuroscience; 2015 Jul; 298():81-93. PubMed ID: 25881725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
    Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y
    J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative assessment of oligomeric amyloid β peptide binding to α7 nicotinic receptor.
    Cecon E; Dam J; Luka M; Gautier C; Chollet AM; Delagrange P; Danober L; Jockers R
    Br J Pharmacol; 2019 Sep; 176(18):3475-3488. PubMed ID: 30981214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status.
    Vallés AS; Borroni MV; Barrantes FJ
    CNS Drugs; 2014 Nov; 28(11):975-87. PubMed ID: 25248971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.